NPI | Name | Type | Address |
---|---|---|---|
PHARMD Kefei Dai |
Individual |
1275 York Ave Bldg S-710 New York, NY |
|
RPH Dina Boulos |
Individual |
160 E 53rd St New York, NY |
|
PHARMD Meagan Barbee |
Individual |
1275 York Ave Schwartz 714 New York, NY |
|
DR. PHARMD Anthony Joseph Proli II |
Individual |
1233 York Ave Rm 307 New York, NY |
|
PHARM.D. Joshua Pecoraro |
Individual |
1275 York Ave S-714 New York, NY |
|
Lora Becker |
Individual |
315 S Manning Blvd Albany, NY |
|
DR. PHARM.D. Ryan Hare |
Individual |
Roswell Park Cancer Institute Elm And Sts Pharmacy Department Buffalo, NY |
|
DR. PHARMD Qiong Yan |
Individual |
1275 York Ave Schwartz 710 New York, NY |
|
RPH Kathryn Sundwall |
Individual |
315 S Manning Blvd Albany, NY |
|
DR. PHARMD Lisa Modelevsky |
Individual |
1275 York Ave New York, NY |
|
Peter Sullivan |
Individual |
1275 York Ave New York, NY |
|
Sinsook Ye |
Individual |
120 Mineola Blvd Mineola, NY |
|
RPH Alison A Tomasulo |
Individual |
903 Helen Ct North Bellmore, NY |
|
PHARMD Adebayo Ogunniyi |
Individual |
1275 York Ave S-710 New York, NY |
|
DR. Amber Courtney King |
Individual |
1250 1st Ave S-710 New York, NY |
|
DR. PHARM.D., BCOP Larry Wayne Buie |
Individual |
1275 York Ave 1275 York Avenue New York, NY |
|
DR. PHARMD Sherry Mathew |
Individual |
1250 1st Ave Dept Of Pharmacy Schwartz Bldg New York, NY |
|
DR. PHARM.D Sarah Mark |
Individual |
1999 Marcus Ave Ste 116 New Hyde Park, NY |
|
RPH Barbara Bortle-gainey |
Individual |
150 55th St Brooklyn, NY |
|
Robert Streitman |
Individual |
36 Hicks Ave Syosset, NY |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |